Pfizer On The Prowl For Generics
This article was originally published in The Pink Sheet Daily
Executive Summary
Only weeks after announcing its Wyeth acquisition, Pfizer is stepping up its profile in the generics world, looking for branded and commodity opportunities.
You may also be interested in...
Pfizer Delves Deeper In Generics Partnership With Strides Arcolab
Pfizer's supply agreement with India-based Strides Arcolab now covers 45 products with a more expansive global marketing reach.
Pfizer Delves Deeper In Generics Partnership With Strides Arcolab
Pfizer's supply agreement with India-based Strides Arcolab now covers 45 products with a more expansive global marketing reach.
Emerging Markets, Biosimilars May Enhance Suitors' Interest In ratiopharm
More than a year after being put up for sale, German generics firm ratiopharm is now said to have three serious suitors: generics giant Teva, Iceland's Actavis and Pfizer